104 related articles for article (PubMed ID: 19381947)
21. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Dai Z; Zhou J; Qiu SJ; Liu YK; Fan J
Electrophoresis; 2009 Sep; 30(17):2957-2966. PubMed ID: 19711376
[TBL] [Abstract][Full Text] [Related]
22. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
23. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
24. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
25. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.
Segu ZM; Hussein A; Novotny MV; Mechref Y
J Proteome Res; 2010 Jul; 9(7):3598-607. PubMed ID: 20405899
[TBL] [Abstract][Full Text] [Related]
26. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
[TBL] [Abstract][Full Text] [Related]
27. Multiplex profiling of glycoproteins using a novel bead-based lectin array.
Wang H; Li H; Zhang W; Wei L; Yu H; Yang P
Proteomics; 2014 Jan; 14(1):78-86. PubMed ID: 24243643
[TBL] [Abstract][Full Text] [Related]
28. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
Zhao J; Qiu W; Simeone DM; Lubman DM
J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
[TBL] [Abstract][Full Text] [Related]
29. Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
Cao J; Shen C; Wang H; Shen H; Chen Y; Nie A; Yan G; Lu H; Liu Y; Yang P
J Proteome Res; 2009 Feb; 8(2):662-72. PubMed ID: 19196183
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the presence of complex high-molecular mass N-linked oligosaccharides in intranuclear glycoproteins from HeLa cells.
Codogno P; Bauvy C; Sève AP; Hubert M; Ogier-Denis E; Aubery M; Hubert J
J Cell Biochem; 1992 Sep; 50(1):93-102. PubMed ID: 1429877
[TBL] [Abstract][Full Text] [Related]
31. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
32. A serial lectin approach to the mucin-type O-glycoproteome of Drosophila melanogaster S2 cells.
Schwientek T; Mandel U; Roth U; Müller S; Hanisch FG
Proteomics; 2007 Sep; 7(18):3264-77. PubMed ID: 17708590
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation of bile-salt-stimulated lipase from human milk: comparison of native and recombinant forms.
Landberg E; Påhlsson P; Krotkiewski H; Strömqvist M; Hansson L; Lundblad A
Arch Biochem Biophys; 1997 Aug; 344(1):94-102. PubMed ID: 9244386
[TBL] [Abstract][Full Text] [Related]
34. A precise approach in large scale core-fucosylated glycoprotein identification with low- and high-normalized collision energy.
Ma C; Zhang Q; Qu J; Zhao X; Li X; Liu Y; Wang PG
J Proteomics; 2015 Jan; 114():61-70. PubMed ID: 25220145
[TBL] [Abstract][Full Text] [Related]
35. A glycoproteomic approach to identify novel glycomarkers for cancer stem cells.
Sawanobori A; Moriwaki K; Takamatsu S; Kamada Y; Miyoshi E
Proteomics; 2016 Dec; 16(24):3073-3080. PubMed ID: 26949200
[TBL] [Abstract][Full Text] [Related]
36. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
37. Expanding the protein catalogue in the proteome reference map of human breast cancer cells.
Pucci-Minafra I; Cancemi P; Fontana S; Minafra L; Feo S; Becchi M; Freyria AM; Minafra S
Proteomics; 2006 Apr; 6(8):2609-25. PubMed ID: 16526084
[TBL] [Abstract][Full Text] [Related]
38. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
40. Identification of sialylated glycoproteins in Doxorubicin-treated hepatoma cells with glycoproteomic analyses.
Azuma K; Serada S; Takamatsu S; Terao N; Takeishi S; Kamada Y; Naka T; Miyoshi E
J Proteome Res; 2014 Nov; 13(11):4869-77. PubMed ID: 25158113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
